✍️ Written by: HOP Medical Centre Health Content Team
📅 Published: August 2026 | 🔄 Last Reviewed: August 2026

Cancer screening in Singapore is the most clinically impactful preventive step most adults will never prioritise until it is too late. At HOP Medical Centre, late-stage cancer diagnoses are among the most consistent and most preventable patterns we encounter in clinical practice. Singapore has one of the highest cancer rates in Asia. Furthermore, most of the cancers responsible for the greatest loss of life — colorectal, breast, cervical, liver, and prostate — are significantly more treatable when detected early through structured screening than when diagnosed after symptoms appear.

The clinical argument for cancer screening is not complicated. Cancer develops through a biological sequence that takes years — often a decade or more. During this sequence, screening tests can detect cellular changes, tumour markers, or structural abnormalities at stages where treatment is far simpler, less invasive, and far more likely to succeed. Waiting for symptoms means waiting until that biological sequence has already progressed well beyond its most manageable stages.

This guide covers which cancers require screening for Singapore adults, at what age and frequency, which tests are involved, and how HOP Medical Centre structures cancer screening programs around individual risk rather than generic package lists.

View Our Cancer Screening Packages

Why Cancer Screening in Singapore Saves Lives

The survival advantage of early cancer detection is substantial — and well-documented across every major cancer type. Understanding this advantage helps adults prioritise screening rather than deferring it indefinitely.

Colorectal cancer detected at Stage 1 carries a five-year survival rate above 90%. The same cancer detected at Stage 4 carries a survival rate below 15%. Breast cancer detected at Stage 1 has a five-year survival rate above 98%. At Stage 4, survival drops sharply. Cervical cancer, when detected at the precancerous stage, is preventable entirely. Liver cancer detected through surveillance in hepatitis B carriers at an early stage is resectable. Discovered symptomatically at an advanced stage, it is rarely so.

These numbers represent clinical realities that early screening changes — not statistics to be read and filed away. Consequently, the decision to screen regularly is, in practical terms, the single most impactful preventive health decision most adults can make after managing blood pressure and blood glucose.

Additionally, cancer screening reduces treatment burden. Early-stage cancer typically requires less aggressive treatment — smaller surgeries, shorter chemotherapy courses, fewer radiotherapy sessions. The physical, financial, and emotional cost of treatment at Stage 1 is substantially lower than at Stage 3 or 4. This reduction in treatment burden benefits both patients and the healthcare system.

The Ministry of Health Singapore recommends structured cancer screening for Singapore adults — specifically colorectal, breast, and cervical cancer — as national health priorities under the Healthier SG and Screen for Life programs.

Which Cancers Should Singapore Adults Screen For?

Colorectal Cancer: Singapore’s Most Common Cancer in Men

Colorectal cancer is the most common cancer in Singaporean men and the second most common in women. Despite this burden, it remains one of the most preventable cancers available to screen for — because it develops almost universally from benign polyps that take years to become cancerous.

Annual FIT testing — a simple stool sample collected at home — detects microscopic blood in the stool that may indicate polyps or early cancer. A positive FIT result prompts colonoscopy — where a gastroenterologist directly visualises the colon, removes polyps during the same procedure, and prevents cancer from developing at all. Consequently, colorectal cancer screening is one of the few cancer screening strategies that is genuinely preventive rather than purely diagnostic.

Adults with a first-degree relative diagnosed with colorectal cancer before age 60 should begin screening ten years earlier than the standard recommendation — or from age 40, whichever comes first. HOP Medical Centre’s Cancer Screening Package includes colorectal screening components structured around individual age and family history.

The Singapore Cancer Society identifies colorectal cancer screening as the highest-priority cancer screening action for Singaporean men — reinforcing why this test should not be deferred beyond age 50 under any circumstances.

Breast Cancer: The Most Common Cancer in Singaporean Women

Breast cancer accounts for nearly 30% of all female cancer cases in Singapore. It is the most common cancer among Singaporean women across every age group from the 20s onwards. Furthermore, Singapore’s breast cancer incidence rate is among the highest in Asia — making regular mammography a clinical standard rather than an optional extra for women from age 40 onwards.

Mammography detects tumours at sizes far smaller than clinical examination or self-examination can feel. Early detection at Stage 1 — when tumours are small and localised — produces five-year survival rates above 98% and typically allows less aggressive surgical treatment. Consequently, the gap between early and late detection in breast cancer is one of the largest in oncology — making regular mammography one of the highest-return clinical investments a woman can make.

Women with dense breast tissue — a category that includes a significant proportion of Asian women — benefit from supplementary ultrasound alongside mammography. Dense tissue can obscure small tumours on standard imaging. HOP Medical Centre’s breast cancer screening service offers both digital mammography and ultrasound, with clinical guidance on which approach suits each patient.

Women with a family history of breast or ovarian cancer — particularly a first-degree relative diagnosed before age 50 — should discuss earlier and more frequent screening with their doctor. BRCA1 and BRCA2 mutation carriers additionally benefit from MRI alongside annual mammography.

Cervical Cancer: Preventable With Consistent Screening

Cervical cancer is one of the most preventable cancers in existence. Over 99% of cervical cancer cases develop from persistent HPV infection — a virus that regular Pap smear and HPV DNA testing reliably detects at the precancerous stage, years before cancer develops.

Women aged 25 to 69 who have ever been sexually active should screen every three years with a Pap smear or every five years with HPV DNA testing. HOP Medical Centre’s cervical cancer screening service offers both options — with clinical guidance on which suits each patient’s age and prior screening history.

HPV vaccination provides additional protection against the HPV strains responsible for most cervical cancers. Vaccination and cervical screening work together — neither replaces the other. Women who have received HPV vaccination should still follow age-appropriate cervical screening guidelines throughout their screening years.

Prostate Cancer: When to Start the Conversation

Prostate cancer is the third most common cancer in Singaporean men. The clinical approach to prostate cancer screening involves more nuance than most other cancers — because PSA testing has both genuine benefits and meaningful limitations that require physician-guided interpretation.

PSA — prostate-specific antigen — is a blood marker produced by the prostate gland. Elevated PSA does not automatically indicate cancer. Benign prostatic hyperplasia, prostatitis, and certain medications all elevate PSA without malignancy. However, a rising PSA trend over multiple years, or a PSA elevation combined with clinical examination findings, triggers further investigation that can detect cancer at early, treatable stages.

Most guidelines recommend discussing PSA testing with a physician from age 50 for average-risk men — or from age 40 to 45 for men with a family history of prostate cancer or those of African descent. The clinical team at HOP Medical Centre discusses the benefits and limitations of PSA testing openly during the consultation — helping each patient make an informed decision rather than simply ordering a test without context.

Liver Cancer and Nasopharyngeal Cancer: Singapore-Specific Priorities

Liver cancer and nasopharyngeal cancer represent two Singapore-specific cancer priorities that differ from the global cancer screening picture. Both reflect Singapore’s unique population genetics and viral disease prevalence — making them particularly important additions to a locally relevant cancer screening program.

For hepatitis B carriers — a significant proportion of adults in Singapore born before the national vaccination program began in 1985 — six-monthly liver cancer surveillance through AFP blood tests and abdominal ultrasound is a clinical standard. Early hepatocellular carcinoma detected through this surveillance is frequently treatable through surgical resection or ablation. Discovered symptomatically at a late stage, the prognosis deteriorates sharply.

Nasopharyngeal cancer screening through EBV antibody testing is particularly relevant for Chinese men in Singapore — the population at highest global risk for this cancer. Early NPC responds well to radiotherapy and carries high cure rates. Late-stage diagnosis significantly reduces treatment effectiveness.

How HOP Medical Centre Structures Cancer Screening Programs

Cancer screening at HOP Medical Centre is built around the principle that the right tests for each individual depend on age, sex, family history, and personal risk profile — not a generic package applied uniformly to all adults.

HOP Medical Centre’s Cancer Screening Package structures age-appropriate cancer markers — including AFP, CEA, CA19-9, CA125, and PSA where relevant — alongside imaging and gender-specific screening components within one coordinated program. The clinical team guides each patient through which markers are clinically warranted for their specific profile rather than simply running every available test.

Additionally, HOP Medical Centre’s Multi-Cancer Early Detection test offers an advanced screening option — using a single blood test to screen for signals associated with multiple cancer types simultaneously. This technology is particularly relevant for adults who want broader cancer surveillance beyond the standard age-specific panel.

For women, HOP Medical Centre’s Women’s Health Screening Package integrates breast, cervical, and cancer marker screening within one coordinated appointment — removing the need for multiple separate bookings across different providers.

The Health Promotion Board Singapore supports structured cancer screening for Singapore adults through the Screen for Life program — covering subsidised colorectal, breast, and cervical cancer screening for eligible Singapore Citizens at participating providers.

Book Your Cancer Screening at HOP Medical Centre

Frequently Asked Questions: Cancer Screening Singapore

Which cancers should Singapore adults screen for?
Singapore adults should prioritise colorectal cancer screening from age 50, breast cancer screening for women from age 40, cervical cancer screening for women aged 25 to 69, and prostate cancer discussion for men from age 50. Hepatitis B carriers require six-monthly liver cancer surveillance. Adults with significant smoking history should discuss lung cancer screening. HOP Medical Centre’s Cancer Screening Package structures these components around individual age, sex, and risk profile rather than applying a uniform menu to all patients.

At what age should cancer screening start in Singapore?
The starting age depends on the cancer type and individual risk factors. Colorectal cancer screening begins at 50 for average-risk adults — earlier with family history. Breast cancer screening begins at 40 for women with average risk. Cervical cancer screening begins at 25 for sexually active women. Prostate cancer discussion begins at 50 for average-risk men. Adults with family history of specific cancers or known genetic risk factors benefit from earlier screening — a physician consultation at HOP Medical Centre establishes the right starting age for each individual.

What are cancer markers and are they reliable for cancer screening?
Cancer markers — also called tumour markers — are proteins or other substances produced by cancer cells or the body in response to cancer. Common markers include CEA (colorectal and gastrointestinal), AFP (liver), CA125 (ovarian), CA19-9 (pancreatic and gastrointestinal), and PSA (prostate). Cancer markers are most useful for monitoring known cancers and assessing treatment response. As standalone screening tools, most markers have limited specificity — they can be elevated for non-cancerous reasons. Consequently, HOP Medical Centre interprets cancer markers alongside clinical history, imaging, and other findings rather than in isolation.

Is cancer screening painful or uncomfortable?
Most cancer screening tests are minimally invasive and well-tolerated. Blood tests for cancer markers involve a standard blood draw. Mammography involves brief breast compression — uncomfortable rather than painful for most women. Pap smears involve mild pressure and brief discomfort during cervical cell collection. Colonoscopy is performed under sedation — patients experience no discomfort during the procedure. FIT testing involves collecting a small stool sample at home. The clinical team at HOP Medical Centre explains each component clearly before the appointment.

Can cancer screening detect all types of cancer?
No. Cancer screening covers specific cancer types where reliable, evidence-based screening tests exist and where early detection produces meaningful treatment benefits. Many cancers — including pancreatic, ovarian, and brain cancers — currently have no reliable population-wide screening method. HOP Medical Centre’s Cancer Screening Package covers the cancer types where structured screening produces the strongest evidence-based clinical benefit for Singapore’s adult population.

More Questions About Cancer Screening in Singapore

How much does cancer screening cost in Singapore?
Cancer screening costs in Singapore vary depending on which tests are included and whether the program is basic or comprehensive. A cancer marker blood panel typically ranges from SGD 150 to SGD 400 depending on the number of markers included. Comprehensive cancer screening packages incorporating imaging and gender-specific screening components are priced higher. Subsidised colorectal, breast, and cervical cancer screening is available for eligible Singapore Citizens through the Screen for Life program. Contact HOP Medical Centre for current Cancer Screening Package pricing.

Is cancer screening covered by insurance or MediSave in Singapore?
Some insurance plans and corporate benefits packages cover cancer screening costs — particularly when a doctor recommends specific tests. The Screen for Life program provides subsidised colorectal, breast, and cervical cancer screening for eligible Singapore Citizens at participating providers. HOP Medical Centre formats reports and documentation to support insurance claims and corporate health benefit submissions. Contact the clinic team to confirm what documentation your specific insurer requires.

What happens if a cancer screening result is abnormal?
An abnormal cancer screening result is a prompt for further investigation — not a cancer diagnosis. Most abnormal results have non-cancerous explanations. A positive FIT result prompts colonoscopy to examine the source of blood. An elevated PSA prompts further clinical assessment including imaging. An abnormal mammogram result prompts additional imaging or biopsy. HOP Medical Centre’s clinical team explains all abnormal results clearly, coordinates follow-up investigations, and supports referral to appropriate specialists where clinically indicated.

How is HOP Medical Centre’s cancer screening different from a basic health check?
A basic health check does not include cancer-specific markers or imaging. HOP Medical Centre’s Cancer Screening Package adds age-appropriate tumour markers — including AFP, CEA, CA19-9, CA125, and PSA where relevant — alongside gender-specific screening components such as mammography, cervical screening, and prostate assessment. The clinical team interprets all findings together rather than as isolated results — giving a clinically coordinated cancer risk picture rather than a disconnected list of numbers.

Screen Now — Before Cancer Decides to Announce Itself

Cancer screening in Singapore is the clinical tool that catches what the body will not tell you until it is too late. The cancers responsible for the greatest burden of suffering and death in Singapore — colorectal, breast, cervical, liver, and prostate — are all detectable at early stages where treatment is far more effective, far less invasive, and far more likely to succeed.

At HOP Medical Centre, cancer screening programs are structured around individual age, sex, family history, and risk profile — not a generic package applied to all adults regardless of clinical relevance. With clinic locations at Orchard (Palais Renaissance) and Tampines (CPF Building), a Cancer Screening Package designed around clinical evidence, and a clinical team experienced in cancer risk assessment, we make proactive cancer screening genuinely accessible and appropriately targeted for Singapore’s adult population.

Explore HOP Medical Centre’s Cancer Screening Package and build a cancer screening program that reflects your actual risk — not a package list that treats every adult the same.